AGP Executive Report
Last update: 10 hours agoLyme Vaccine Push in Europe: The EMA has agreed to study an experimental Lyme disease vaccine from Valneva and Pfizer, after trials showed about 70% efficacy for ages 5+—a big deal for Central Europe, where tick season is stretching and Slovenia is among the higher-incidence countries. Retirement Travel Costs: A new global map estimates what it takes for Americans to “retire comfortably” abroad—Singapore tops the list at about $1.1M, while Pakistan is cheapest—while also highlighting that healthcare and taxes can swing the real picture. Senior-Friendly Travel Picks: Another study ranks Japan as the best destination for older travelers, citing senior discounts, walkability, safety, and healthcare access—useful for anyone planning a “golden gap year.” Local Health Context: With tick-borne illness on the rise and Slovenia named among the hardest-hit areas, the vaccine review is the week’s most directly relevant health update for our readers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
